Cargando…
Drug Repurposing in Cancer Therapy: Influence of Patient’s Genetic Background in Breast Cancer Treatment
Cancer is among the leading causes of death worldwide and it is estimated that in 2040 more than 29 million people will be diagnosed with some type of cancer. The most prevalent type of cancer in women, worldwide, is breast cancer, a type of cancer associated with a huge death rate. This high mortal...
Autores principales: | Rodrigues, Rafaela, Duarte, Diana, Vale, Nuno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028365/ https://www.ncbi.nlm.nih.gov/pubmed/35457144 http://dx.doi.org/10.3390/ijms23084280 |
Ejemplares similares
-
Drug combination and repurposing for cancer therapy: the example of breast cancer
por: Correia, Ana Salomé, et al.
Publicado: (2021) -
Repurposing of the Drug Tezosentan for Cancer Therapy
por: Ribeiro, Eduarda, et al.
Publicado: (2023) -
Repurposed Drugs in Gastric Cancer
por: Araújo, Diana, et al.
Publicado: (2022) -
Pharmacological Efficacy of Repurposing Drugs in the Treatment of Prostate Cancer
por: Lourenço, Tânia, et al.
Publicado: (2023) -
Drug Combinations: A New Strategy to Extend Drug Repurposing and Epithelial-Mesenchymal Transition in Breast and Colon Cancer Cells
por: Duarte, Diana, et al.
Publicado: (2022)